Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial - Glund, S; Stangier, J; Schmohl, M (Lancet, 2015)
(9994):